World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
30403
World Ranking
12186
National Ranking
6249

Overview

Marc C. Chamberlain is affiliated with the University of Washington in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in related subfields such as Genetics, Immunology, Oncology, Surgery, and Pulmonary and Respiratory Medicine.

The scientist's work encompasses several medically relevant topics, notably in neuro-oncology and cancer immunology. Main topics of their research include:

  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Immune cells in cancer
  • Inflammation biomarkers and pathways
  • Management of metastatic bone disease
  • Inflammatory Biomarkers in Disease Prognosis
  • Meningioma and schwannoma management

Marc C. Chamberlain has published extensively in multiple venues, with a concentration in neuro-oncological journals. Frequent publication venues include:

  • Neuro-Oncology
  • Neuro-Oncology Advances
  • Journal of Clinical Oncology
  • Investigational New Drugs
  • Journal for ImmunoTherapy of Cancer

Recent publications by Chamberlain include the following:

  • "A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma," 2020, Neuro-Oncology
  • "A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma," 2022, Neuro-Oncology Advances
  • "A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma," 2024, Investigational New Drugs
  • "A phase 1a dose-escalation study of PY314, a TREM2 (Triggering Receptor Expressed on Macrophages 2) targeting monoclonal antibody," 2022, Journal of Clinical Oncology
  • "Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma," 2024, Neuro-Oncology Advances

The scientist frequently collaborates with other researchers. Their most common co-authors include:

  • Amita Patnaik
  • Ira Winer
  • Nadine S. Jahchan
  • Winston Tan
  • Christos E. Kyriakopoulos

Best Publications

  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy

  • Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology

    M. J. Glantz;B. F. Cole;B. F. Cole;P. A. Forsyth;L. D. Recht;L. D. Recht

  • Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

    Nathalie L. Albert;Michael Weller;Bogdana Suchorska;Norbert Galldiks

  • A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

    Michael J. Glantz;Michael J. Glantz;Kurt A. Jaeckle;Marc C. Chamberlain;Surasak Phuphanich

  • Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

    M. J. van den Bent;J. S. Wefel;D. Schiff;M. J. B. Taphoorn

  • Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

    Wolfgang Wick;Vinay K. Puduvalli;Marc C. Chamberlain;Martin J. van den Bent

  • Neoplastic meningitis

    Ana Aparicio;Marc C. Chamberlain

  • Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

    Michael J. Glantz;Suzanne LaFollette;Kurt A. Jaeckle;William Shapiro

  • Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

    Marc C. Chamberlain;Michael J. Glantz;Lisa Chalmers;Alixis Van Horn

  • Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report.

    Sigal Grisariu;Batia Avni;Tracy T. Batchelor;Martin J. van den Bent

  • Adult primary intradural spinal cord tumors: a review.

    Marc C. Chamberlain;Trent L. Tredway

  • Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain.

    Marc C. Chamberlain;Arthur D. Sandy;Gary A. Press

  • Leptomeningeal metastases: a RANO proposal for response criteria.

    Marc Chamberlain;Larry Junck;Dieta Brandsma;Riccardo Soffietti

  • Radiographic patterns of relapse in glioblastoma.

    Marc C. Chamberlain

  • Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review

    Thomas Kaley;Igor Barani;Marc Chamberlain;Michael McDermott

  • Central Nervous System Cancers

    Louis Burt Nabors;Mario Ammirati;Philip J. Bierman;Henry Brem

  • Recurrent meningioma Salvage therapy with long-acting somatostatin analogue

    Marc C. Chamberlain;Michael J. Glantz;Camilo E. Fadul

  • Temozolomide for treatment-resistant recurrent meningioma

    Marc C. Chamberlain;Denice D. Tsao-Wei;Susan Groshen

  • Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.

    Marc C. Chamberlain;Michael Glantz;Morris D. Groves;Wyndham H. Wilson

  • Leptomeningeal metastases: A rano proposal for response criteria.

    Marc C. Chamberlain;Larry Junck;Dieta Brandsma;Riccardo Soffietti

Frequent Co-Authors

Patrick Y. Wen
Patrick Y. Wen Harvard University
David Schiff
David Schiff University of Virginia
Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
Lisa M. DeAngelis
Lisa M. DeAngelis Memorial Sloan Kettering Cancer Center
Mark R. Gilbert
Mark R. Gilbert National Institutes of Health
David A. Reardon
David A. Reardon Harvard University
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam
Stuart A. Grossman
Stuart A. Grossman Johns Hopkins University
Victor A. Levin
Victor A. Levin The University of Texas MD Anderson Cancer Center
Michael D. Prados
Michael D. Prados University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a healthcare career but not ready for the long commitment of an MD program, several online alternatives offer flexible, affordable paths. Many registered nurses are upgrading their credentials through the cheapest online bsn programs, which often allow you to juggle work and study.

For those with a bachelor’s degree in another field, direct entry msn programs for non-nurses online pave a streamlined pathway to a master’s in nursing, opening up fast-track routes into advanced practice roles.

If you’re looking for accessibility and less competition, nursing schools with high acceptance rates can be a smart starting point. These schools offer more opportunities for applicants who may not have perfect academic backgrounds.

Not all medical careers require direct patient care—roles in healthcare administration are growing. Programs listed among the financial aid for medical billing and coding online classes make it possible to enter this in-demand sector, often with robust financial assistance options.

Best Scientists Citing Marc C. Chamberlain

Trending Scientists

Recently Published Articles